New!
,

Cellular therapy compliance guide

Sorting through the extensive list of regulations for CGMPs and CGTPs to ensure you are in compliance can seem overwhelming. We've compiled a comprehensive overview of those regulations for your reference.
, , , , , , , , , , , , , , , , , ,

Basic infection and control procedures

In this free video, Barbara Katz, RN, MSN reviews basic infection prevention and control procedures that are critical in helping to protect you and your colleagues from spreading COVID-19.
,

Restoring lung growth with intranasal delivery of stem cells

Bronchopulmonary dysplasia (BPD) is a devastating lung condition that develops in premature newborns. Dr. Alvaro Moreira presents on advances in regenerative medicine that may provide a novel approach to BPD.
,

Simplifying data management for BMT programs and cell therapy labs

Good data management is required to maintain quality and process control, evaluate therapies, and to meet regulatory requirements for BMT programs. Learn how a single platform can help.
,

Transitioning to the Seventh Edition NetCord-FACT International Cord Blood Standards

Paul Eldridge, PhD, describes significant changes to the NetCord-FACT international cord blood standards and provides implementation examples.
,

Share the Science: HLA matching for cord blood units

Discover what information is needed to select the most optimal cord blood unit based on HLA profiles.
,

Driving public banked cord blood inventory utilization through R&D

In this presentation, Marcie Finney discusses ways in which cord blood banks can optimize inventory by identifying industry drivers, managing acquisition costs, and promoting innovation in research.
,

Alternative donor stem cell transplantation

In this presentation, Dr. Karen Ballen discusses the opportunities and challenges presented by allogenic stem cell transplantation and reviews recent data on umbilical cord blood transplant and minimal residual disease.
,

CAR-T data management simplified

The growing use of CAR-T therapy presents new data management challenges for both clinics and labs. WellSky Biotherapies can help solve them.
,

Clinical translation of perinatal cells in an academic facility

Dr. Julie Allickson, Director of the Regenerative Medicine Clinical Center at Wake Forest Institute for Regenerative Medicine provides information on clinically translating perinatal cells in an academic facility.
,

Delayed umbilical cord clamping and its impact on blood collection

ViaCord’s Director of Medical and Scientific Affairs Kate Girard, RN, MSN, presents a comprehensive overview of cord clamping and the collection of umbilical cord blood for banking.
,

Clinical outcomes after cord blood transplantation

Join us as Dr. Filippo Milano shares how cord blood can be associated with a lower risk of relapse in patients with high risk hematological malignancies, as well as exciting data regarding lower risk of Graft Versus Host Disease (GVHD) in patients receiving cord blood.
,

Cellular therapy accreditation

Insights and guidance for completing the process and maintaining accreditation.
,

Share the Science presents: The sustainability of the national cord blood system

Join us as Kandice Kapinos of the RAND Corporation presents their findings on the sustainability of the national cord blood system.
,

Share the Science presents: How to ensure proper lab sanitization for cord blood processing labs

Learn best practices for keeping cord blood processing laboratory clean, sanitized, and disinfected - crucial for product quality and safety.
,

Share the Science presents: stem cell therapies for autism

Michael G. Chez, M.D. presents a broad overview of past and current trials applying stem cell therapy to autism spectrum disorders, as well as future therapeutic opportunities. Co-sponsored by Save the Cord Foundation.